Evidence map›Paper›PMID 27646594›Full record

ArticleScientific reports2016

Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock.

Arjun Balakrishnan, Priya DasSarma, Oindrilla Bhattacharjee, Jong Myoung Kim, Shiladitya DasSarma, Dipshikha Chakravortty

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Serum BPI as a novel biomarker in asthma.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Arjun BalakrishnanDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.
Priya DasSarmaInstitute of Marine and Environmental Technology and Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.
Oindrilla BhattacharjeeDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.
Jong Myoung KimInstitute of Marine and Environmental Technology and Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.
Shiladitya DasSarmaInstitute of Marine and Environmental Technology and Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.
Dipshikha ChakravorttyDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.
Indian Institute of Science Bangalore · INUniversity of Maryland, Baltimore · US

Funding

A Bioengineerable Self-adjuvating Nanoparticle for Antigen DeliveryR03AI107634 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI DASSARMA, SHILADITYA · 2013 to 2014
$154k
NIAID NIH HHS R03 AI107634
6 · The paper itself

Abstract

Bactericidal/permeability-increasing protein (BPI) had been shown to possess anti-inflammatory and endotoxin neutralizing activity by interacting with LPS of Gram-negative bacteria. The current study examines the feasibility of using murine BPI (mBPI) expressed on halophilic Archaeal gas vesicle nanoparticles (GVNPs) for the treatment of endotoxemia in high-risk patients, using a murine model of D-galactosamine-induced endotoxic shock. Halobacterium sp. NRC-1was used to express the N-terminal 199 amino acid residues of mBPI fused to the GVNP GvpC protein, and bound to the surface of the haloarchaeal GVNPs. Our results indicate that delivery of mBPIN-GVNPs increase the survival rate of mice challenged with lethal concentrations of lipopolysaccharide (LPS) and D-galactosamine. Additionally, the mBPIN-GVNP-treated mice displayed reduced symptoms of inflammation, including inflammatory anemia, recruitment of neutrophils, liver apoptosis as well as increased pro-inflammatory serum cytokine levels.

Indexed as

AnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesApoptosisBlood ProteinsCytokinesCytoplasmic VesiclesFemaleGene ExpressionHalobacteriumHost-Pathogen InteractionsInflammation MediatorsLipopolysaccharidesLiverMiceProtein BindingAnti-Bacterial AgentsAntimicrobial Cationic Peptidesbactericidal permeability increasing proteinBlood ProteinsCytokinesInflammation MediatorsLipopolysaccharides

Identifiers

PMID27646594
PMCPMC5028748
OpenAlexW2460363770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.